Contents
Download PDF
pdf Download XML
441 Views
165 Downloads
Share this article
Research Article | Volume 9 Issue :2 (, 2019) | Pages 43 - 45
Predictive Ability of Total Serum Bilirubin at 24 Hours for Development of Subsequent Neonatal Hyperbilirubinemia- an observational study in a tertiary care hospital
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
June 26, 2019
Abstract

Background and Objectives: Jaundice is the commonest abnormal physical finding during 1st week of life. The objective of our study is to observe the predictive ability of Total Serum Bilirubin at 24 hours of life for development of subsequent neonatal hyperbilirubinemia.

 

Materials and Methods: 210 term and preterm newborns without any significant illness or congenital malformation admitted from July 2017 to June 2018 were studied by serum bilirubin estimation at 24 hours and followed up.

 

Results: Results of the study showed total serum bilirubin of >6mg/dl at 24 hours had a positive predictive value of 73.23% and negative predictive value of 97.12%

 

Interpretation and Conclusion: Early prediction of neonatal hyperbilirubinemia offers an attractive option to reduce bilirubin induced brain damage.

Keywords
Recommended Articles
Research Article
Expert Consensus on the Role of Bempedoic Acid in the Management of Dyslipidemia and Statin Intolerance in Indian Patients: Evidence, Clinical Insights, and Practical Recommendations
...
Published: 26/03/2026
Download PDF
Research Article
Evaluation of tracheoesophageal fistula patients – diagnosis, outcome and prognosis at a tertiary care centre
...
Published: 03/04/2026
Download PDF
Research Article
A STUDY ON SOCIETY OF VASCULAR SURGERY – WOUND, ISCHEMIA, FOOT INFECTION (SVS-WIFi) SCORING SYSTEM AND ITS ROLE IN RISK STRATIFICATION OF DIABETIC FOOT ULCERS.
...
Published: 03/04/2026
Download PDF
Research Article
A Prospective Study of Adverse Drug Reactions in a Tertiary Care Hospital
Published: 17/03/2021
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.